Search results for "ship"

showing 10 items of 6731 documents

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

2012

BACKGROUND: Some patients with severe asthma have recurrent asthma exacerbations associated with eosinophilic airway inflammation. Early studies suggest that inhibition of eosinophilic airway inflammation with mepolizumab-a monoclonal antibody against interleukin 5-is associated with a reduced risk of exacerbations. We aimed to establish efficacy, safety, and patient characteristics associated with the response to mepolizumab. METHODS: We undertook a multicentre, double-blind, placebo-controlled trial at 81 centres in 13 countries between Nov 9, 2009, and Dec 5, 2011. Eligible patients were aged 12-74 years, had a history of recurrent severe asthma exacerbations, and had signs of eosinophil…

AdultMalemedicine.medical_specialtyAdolescentPlacebo-controlled studyFevipiprantAntibodies Monoclonal HumanizedPlaceboLebrikizumabDrug Administration ScheduleLeukocyte CountYoung Adultchemistry.chemical_compoundDouble-Blind MethodReslizumabInternal medicineSecondary PreventionmedicineHumansAnti-Asthmatic AgentsPulmonary EosinophiliaChildGlucocorticoidsAgedAsthmaDose-Response Relationship Drugbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseBenralizumabAsthmaEosinophilsTreatment OutcomechemistryPhysical therapyDrug Therapy CombinationFemaleInterleukin-5businessMepolizumabmedicine.drugThe Lancet
researchProduct

Treatment of human brucellosis with rifampin plus minocycline

2003

In order to evaluate the efficacy and tolerability of a high intravenous dose of rifampin plus oral minocycline (administered daily for 3 weeks) for the treatment of acute brucellosis, we retrospectively reviewed the outcome of 239 consecutive patients (135 adults and 104 children) diagnosed and treated over a 17-year period in Italy. The combination used resulted in 100% response and a relapse rate lower than 2%. Fifty-two (30 adults and 22 children) (29.8%) complained of mild adverse effects including an increase in aspartate aminotransferase (>250 IU) observed in 12 cases and considered related to rifampin and in 11 cases a reversible hyperpigmentation of the tongue attributed to minocyc…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentMinocyclineRisk AssessmentDrug Administration SchedulePharmacotherapyRecurrenceInternal medicinemedicineHumansPharmacology (medical)ChildInfusions IntravenousAdverse effectAgedRetrospective StudiesAntibacterial agentAged 80 and overPharmacologyChemotherapyDose-Response Relationship Drugbusiness.industryRetrospective cohort studyMinocyclineMiddle AgedBrucellaSurgeryTreatment OutcomeInfectious DiseasesItalyOncologyTolerabilityChild PreschoolbrucellosisDrug Therapy CombinationFemaleRifampinbusinessRifampicinFollow-Up Studiesmedicine.drug
researchProduct

Subjective, behavioral, and physiological responses to the rubber hand illusion do not vary with age in the adult phase.

2018

[EN] The Rubber Hand Illusion (RHI) is a perceptual illusion that enables integration of artificial limbs into the body representation through combined multisensory integration. Most previous studies investigating the RHI have involved young healthy adults within a very narrow age range (typically 20-30 years old). The purpose of this paper was to determine the influence of age on the RHI. The RHI was performed on 93 healthy adults classified into three groups of age (20-35 years old, N = 41; 36-60 years old, N = 28; and 61-80 years old, N = 24), and its effects were measured with subjective (Embodiment of Rubber Hand Questionnaire), behavioral (proprioceptive drift), and physiological (cha…

AdultMalemedicine.medical_specialtyAgingmedia_common.quotation_subjectSkin temperatureIllusionExperimental and Cognitive PsychologyAudiologyRubber hand illusion050105 experimental psychologyDevelopmental psychology03 medical and health sciencesEmbodimentYoung Adult0302 clinical medicineArts and Humanities (miscellaneous)Age groupsTEORIA DE LA SEÑAL Y COMUNICACIONESDevelopmental and Educational PsychologymedicineMultisensory integrationHumans0501 psychology and cognitive sciencesmedia_commonAgedAged 80 and overProprioceptionPerceptual illusion05 social sciencesSkin temperatureMultisensory integrationINGENIERIA TELEMATICAGalvanic Skin ResponseMiddle AgedHandProprioceptionIllusionsArtificial limbsPhysiological responsesTouch PerceptionSkin conductanceVisual PerceptionFemalePsychologyBody-ownershipSkin Temperature030217 neurology & neurosurgeryConsciousness and cognition
researchProduct

Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dos…

2015

ABSTRACT Isavuconazole is a novel broad-spectrum triazole antifungal agent. This open-label dose escalation study assessed the safety and pharmacokinetics of intravenous isavuconazole prophylaxis in patients with acute myeloid leukemia who had undergone chemotherapy and had preexisting/expected neutropenia. Twenty-four patients were enrolled, and 20 patients completed the study. The patients in the low-dose cohort ( n = 11) received isavuconazole loading doses on day 1 (400/200/200 mg, 6 h apart) and day 2 (200/200 mg, 12 h apart), followed by once-daily maintenance dosing (200 mg) on days 3 to 28. The loading and maintenance doses were doubled in the high-dose cohort ( n = 12). The mean ± …

AdultMalemedicine.medical_specialtyAntifungal AgentsNeutropeniaPyridinesClinical TherapeuticsNeutropeniaCohort StudiesPharmacokineticsInternal medicineNitrilesHumansMedicinePharmacology (medical)DosingAdverse effectAgedImmunosuppression TherapyPharmacologyDose-Response Relationship Drugbusiness.industryMiddle AgedTriazolesmedicine.diseaseIsavuconazoniumSurgeryLeukemia Myeloid AcuteInfectious DiseasesMycosesTolerabilityCohortFemalePatient Safetybusinessmedicine.drugCohort studyAntimicrobial Agents and Chemotherapy
researchProduct

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

2011

To define better the safety profile of micafungin, an analysis of micafungin clinical trial safety data was undertaken.Adverse event data were pooled worldwide from 17 clinical efficacy and safety studies. Adverse events were coded using the Medical Dictionary for Regulatory Activities version 5.0.In the pooled clinical trial data set, 3028 patients received at least one dose of micafungin. The mean age of patients was 41.4 years; with 296 (9.8%) children (16 years) and 387 (12.8%) elderly patients (≥ 65 years). Common underlying conditions were hematopoietic stem cell and other transplantations (26.1%), malignancies (20.8%) and HIV (32.9%). Mean exposure was 18 days for adults and 29 days …

AdultMalemedicine.medical_specialtyAntifungal AgentsTime FactorsAdolescentDatabases FactualNauseaMedDRAEchinocandinsLipopeptidesYoung AdultInternal medicinemedicineHumansPharmacology (medical)ChildAdverse effectAgedAged 80 and overClinical Trials as TopicDose-Response Relationship Drugbusiness.industryAge FactorsMicafunginInfantGeneral MedicineMiddle AgedHypokalemiaSurgeryClinical trialDiarrheaMycosesChild PreschoolMicafunginVomitingFemalemedicine.symptombusinessmedicine.drugExpert Opinion on Drug Safety
researchProduct

Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis

2020

Purpose Voriconazole was shown to inhibit ergosterol synthesis in various acanthamoeba species. The purpose of this study was to evaluate the clinical outcome of treatment with supplemental topical voriconazole in patients with acanthamoeba keratitis (AK). Methods All patients who had been treated for AK with voriconazole 1% drops in conjunction with topical first-line antiacanthamoeba therapy composed of polyhexamethylene biguanide (PHMB) 0.02% and propamidine isethionate 0.1% (Brolene) between November 2014 and August 2017 at the Department of Ophthalmology, University Medical Center Mainz, were included. The main outcomes were treatment failure and recurrence rate. Secondary outcomes wer…

AdultMalemedicine.medical_specialtyAntifungal AgentsVisual acuitymedicine.drug_classAntiprotozoal AgentsVisual AcuityAcanthamoebaCorneaYoung Adult03 medical and health sciences0302 clinical medicinePharmacotherapymedicineAnimalsHumansIn patientEye Infections ParasiticAgedRetrospective StudiesAged 80 and overVoriconazoleDose-Response Relationship Drugbusiness.industryBiguanideRetrospective cohort studyMiddle AgedEye infectionmedicine.diseaseDermatologyBenzamidinesOphthalmologyAcanthamoeba KeratitisAcanthamoeba keratitis030221 ophthalmology & optometryDrug Therapy CombinationFemaleVoriconazoleOphthalmic Solutionsmedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up Studiesmedicine.drugCornea
researchProduct

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targ…

2006

BACKGROUND: Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome. METHODS: The TNT study was a prospective, double blind, parallel-group trial done at 256 sites in 14 countries between April, 1998, and August, 2004, with a median follow-…

AdultMalemedicine.medical_specialtyAtorvastatinCoronary Diseaselaw.inventionDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodRandomized controlled trialRisk FactorslawInternal medicineDiabetes mellitusAtorvastatinmedicineHumansPyrrolesMyocardial infarctionStrokeAgedMetabolic SyndromeDose-Response Relationship Drugbusiness.industryCholesterolAnticholesteremic AgentsHazard ratioCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseSurgerychemistryCardiovascular DiseasesHeptanoic AcidsCardiologyFemaleMetabolic syndromebusinessmedicine.drug
researchProduct

Factors associated with GPs' knowledge of their patients' socio-economic circumstances: a multilevel analysis.

2015

A paraître; International audience; Background. To determine appropriate management for individual patients, GPs are supposed to use their knowledge of the patient's socio-economic circumstances.Objective. To analyse factors associated with GPs' knowledge of these circumstances.Methods. Observational survey of GPs who were internship supervisors in the Paris metropolitan area. Each of 52 volunteer GPs completed a self-administered questionnaire about their own characteristics and randomly selected 70 patients from their patient list. Their knowledge was analysed as the agreement between the patients' and GPs' responses to questions about the patients' socio-economic characteristics in quest…

AdultMalemedicine.medical_specialtyAttitude of Health PersonneleducationEconomicInsurance Coverage[SHS]Humanities and Social SciencesContinuing medical educationGeneral PractitionersInternshipSurveys and QuestionnairesMedicineHumansDuration (project management)Practice Patterns Physicians'AgedPhysician-Patient Relationsbusiness.industryMedical recordMultilevel modelSocial environmentMiddle Aged[SHS.ECO]Humanities and Social Sciences/Economics and Finance3. Good healthWork (electrical)Socioeconomic FactorsFamily medicineGlobal Positioning SystemMultilevel AnalysisFemaleFranceFamily PracticebusinessFamily practice
researchProduct

Post-doctoral mentorship award : have you considered applying?

2017

AdultMalemedicine.medical_specialtyAwards and PrizesMEDLINEAlternative medicineEligibility Determination030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineMentorshipPhysiciansHumansMedicineEligibility DeterminationAdvanced and Specialized NursingMedical education030504 nursingbusiness.industryMentorsMiddle AgedSettore MED/45 - Scienze Infermieristiche Generali Cliniche e PediatricheMedical–Surgical NursingFemaleHuman medicine0305 other medical scienceCardiology and Cardiovascular MedicinebusinessEuropean journal of cardiovascular nursing
researchProduct

Multisectorial changes in the ciliary muscle during accommodation measured with high-resolution optical coherence tomography

2019

ABSTRACT Purpose: To measure changes in the anterior ciliary muscle during accommodation at the nasal, superior, temporal, and inferior sectors by means of an anterior chamber optical coherence tomographer, and correlate them with vergence changes. Methods: Twenty-four subjects with healthy, phakic eyes, whose mean age was 27.1 ± 8.9 years, underwent measurement with an anterior chamber optical coherence tomographer. The anterior ciliary muscle was measured at the nasal, temporal, superior, and inferior sectors for 0, -1, -2, and -3 D of vergence. A linear model was used to assess the correlation of each eye parameter with the accommodative demand. Results: The anterior ciliary muscle area …

AdultMalemedicine.medical_specialtyBiometryHigh resolutionVergenceStatistics NonparametricYoung Adult03 medical and health sciences0302 clinical medicinelcsh:OphthalmologyOptical coherence tomographyReference ValuesOphthalmologyHumansMedicineTomographyMúsculo ciliarBiometriaAnalysis of Variancemedicine.diagnostic_testbusiness.industryCiliary BodyOptical coherenceBiomechanicsAccommodation OcularPresbyopiaGeneral MedicinePresbyopiamedicine.diseaseBiomechanical PhenomenaCiliary muscleOphthalmologyCiliary musclelcsh:RE1-994Acomodação ocularTomografia de coerência ópticaAccommodation ocularLinear Models030221 ophthalmology & optometryPositive relationshipFemalesense organsPresbiopiabusinessAccommodationTomography Optical CoherenceArquivos Brasileiros de Oftalmologia
researchProduct